Latest News about OCUL
Recent news which mentions OCUL
Earnings Scheduled For May 9, 2022
May 09, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
April 17, 2022
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
From Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
December 06, 2021
Tickers
OCUL
From Benzinga
3 Small-Cap Stocks to Buy Now and Hold for the Long Haul
November 20, 2021
From Motley Fool
Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati
November 09, 2021
Tickers
OCUL
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 09, 2021
From Benzinga
Earnings Scheduled For November 8, 2021
November 08, 2021
From Benzinga
What 5 Analyst Ratings Have To Say About Ocular Therapeutix
October 25, 2021
Tickers
OCUL
From Benzinga
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
October 25, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
October 25, 2021
From Benzinga
55 Biggest Movers From Friday
October 25, 2021
From Benzinga
From Motley Fool
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 22, 2021
From Benzinga
From Benzinga
35 Stocks Moving In Friday's Mid-Day Session
October 22, 2021
From Benzinga
3 Great Stocks You Can Buy With $50 Right Now
October 20, 2021
From Motley Fool
10 Biggest Price Target Changes For Monday
October 18, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
|
|
|
|